Stoboclo and Osenvelt, FDA-approved biosimilars of Prolia and Xgeva, are now available in the U.S. for variois cancers and ...

The US biosimilar market expands with new denosumab options, enhancing treatment for patients with osteoporosis and ...

Bone health expert Debi Robinson joined Gayle Guyardo, host of the globally syndicated health and wellness show Bloom, to ...

Dad felt like he was ‘walking in flippers’ before incurable cancer diagnosis - Mart Roe’s symptoms were initially dismissed ...